Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Multicenter, Single-Blind, Placebo-Controlled, Multiple Cohort Study Evaluating ABI-H2158-Containing Regimens in Chronic Hepatitis B Infection

NCT04398134 is registered in ClinicalTrials.gov with Assembly Biosciences as lead sponsor.

NCT NCT04398134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04398134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Multicenter, Single-Blind, Placebo-Controlled, Multiple Cohort Study Evaluating ABI-H2158-Containing Regimens in Chronic Hepatitis B Infection
Lead sponsor
Assembly Biosciences
Phase
Phase 2
Overall status
Terminated
Start date
August 28, 2020
Completion date
December 28, 2021
Enrollment
88 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b